Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst (Nasdaq: HCAT) will announce its 2020 third quarter operating results on November 10, 2020, after market close. The company provides data and analytics technology to healthcare organizations, aiming for measurable healthcare improvement. A conference call will follow at 5 p.m. E.T., accessible by phone or via a live audio webcast. Health Catalyst's platform draws from over 100 million patient records, enabling clients to make data-informed decisions for operational and financial improvements.
Health Catalyst (Nasdaq: HCAT) announced the appointment of Amanda Hundt as the new Vice President of Corporate Communications. This role aims to strengthen the communications team's capacity to support the company’s growth and market expansion strategies. Hundt will develop innovative external communications and public relations strategies while contributing to diversity and inclusion initiatives. With her extensive experience in health and technology communications, Hundt is expected to enhance Health Catalyst's mission of data-informed healthcare improvement.
Health Catalyst, a top provider of healthcare data and analytics technology, announced participation in the 2020 Cantor Global Virtual Healthcare Conference. CFO Patrick Nelli and SVP Adam Brown will engage in a fireside chat on September 15, 2020, at 1:20 p.m. ET. A live audio webcast will be available at Health Catalyst's investor relations site. The company utilizes a comprehensive cloud-based data platform, analyzing over 100 million patient records to improve healthcare decisions and outcomes.
Health Catalyst (HCAT) successfully completed its seventh annual Healthcare Analytics Summit, registering over 3,500 attendees. Additionally, the acquisition of Vitalware, a Yakima-based SaaS provider, has been finalized, enhancing Health Catalyst's Data Operating System (DOS). The integration aims to improve revenue workflow optimization for healthcare organizations. CEO Dan Burton announced that while the acquisition’s immediate impact on Q3 2020's financial performance will be minimal, it will feature in the full-year guidance. Key leadership changes were also noted, including the transition of CTO Dale Sanders to Senior Advisor.
Health Catalyst (HCAT) has announced a strategic partnership with Northwell Health, aimed at improving patient care through enhanced data and analytics capabilities. This collaboration will utilize Health Catalyst's cloud-based solutions to optimize data management and integration with Electronic Medical Records (EMR). Northwell, the largest healthcare provider in New York, aims to leverage insights from Health Catalyst's offerings to better serve over 11 million patients. The initiative also includes access to COVID-19 specific tools, further supporting Northwell's mission to transform healthcare delivery.
Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire Vitalware, a provider of revenue workflow optimization technology based in Yakima, Washington. Vitalware's solutions include a Best in KLAS chargemaster management tool and products for Revenue Integrity and Price Transparency. This acquisition aims to enhance Health Catalyst’s analytics capabilities on its DOS™ platform, integrating charge and revenue data with claims and cost data. The transaction will be funded through a mix of cash and stock and is expected to close in Q3 or Q4 of 2020.
Health Catalyst (Nasdaq: HCAT) announced participation in two upcoming virtual investor conferences. Dan Burton (CEO), Patrick Nelli (CFO), and Adam Brown (SVP, Investor Relations) will be featured. The first event is the Verity Research HCIT / Services Conference on August 12, 2020, at 4:00 p.m. EST, followed by the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 10:00 a.m. EST. Health Catalyst focuses on healthcare improvement through data and analytics, leveraging over 100 million patient records to support informed decision-making.
On July 28, 2020, Health Catalyst (Nasdaq: HCAT) announced its new Financial Impact Recovery applications aimed at helping healthcare systems recover financially from the effects of COVID-19. These tools enable hospitals to prioritize and monitor backlogs in elective surgeries and outpatient visits, while also streamlining revenue cycles. With rapid implementation timelines, the applications have already been adopted by 15 clients, including Banner Health, which emphasized their need for timely data analytics to enhance financial performance amid the pandemic.
Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire healthfinch, a company that enhances EMR workflows through automation and analytics. This acquisition aims to strengthen Health Catalyst's Population Health portfolio, previously bolstered by the Able Health acquisition. The healthfinch technology will be integrated into Health Catalyst’s Data Operating System, providing actionable insights and improving patient care efficiency. The transaction is expected to close in Q3 2020 and will be funded through a mix of stock and cash.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
